- What We Do
- Who We Are
Managing director Hagihara and persons responsible for China market entry support services met with 4 partner organizations in a span of 5 days starting October 17th. SunFlare’s China market entry support services consists of business support services in 3 fields – intellectual property strategy, regulatory affairs, and standards compliance The 3 organizations who will partner with SunFlare to support clients entering the China market are Pharmtec , China Beijing Equity Exchange , and Venturepharm. Additionally, a meeting with the parent organization of China Technology Exchange, China Beijing Equity Exchange , took place. At the meetings, common hurdles Japanese firms face when entering the Chinese market and possible solutions were discussed with the top level management of each respective organization.
Pharmtec attendees: Pharmtec president Mr. Rui, Manager of the CRO division Mr. Zhao, Manager of the consulting division Mr. Zhang, Manager of the technical evaluation and technology transfer division Mr. Liu, Manager of the media communications division Mr. Qin, and deputy editor of industry publication “Chinese Journal of Pharmaceutical Technology Economics and Management”, Mr. Huang.
Attendees from CTEX: Vice Chairman Xu, Manager of Technology Exchange Service Center Mr. Li, and Senior Manager Mr. Shan.
Attendees from CBEX: Manager of Strategies Department Mr. Xia, Senior Manager of Strategies department Mr. Li.
Venturepharm attendees: CEO Mr. Song, R&D Division Director Mr. Lu and manager Mr. Wu, and Clinical Trials Division manager Mr. Zhu.Finally, during this visit, SunFlare conducted discussions with Xi Tingfei Peking University professor and former director of Center of Medical Devices, National Institute for the Control of Pharmaceutical and Biological Products. As a solution for medical device manufacturers entering China, SunFlare will be holding a seminar on the Chinese regulatory framework, and will be inviting Mr. Xi to provide insight as lecturer.